Abstract
Inflammation of the external auditory canal can be localised or diffuse, and acute or chronic. Predisposing conditions include external trauma, loss of the canal’s protective coating, maceration of the skin from water or humidity, and glandular obstruction. Acute otitis externa is generally caused by Pseudomonas aeruginosa or Staphylococcus aureus. Management of patients with otitis externa includes debridement, topical therapy with acidifying and antimicrobial agents, and systemic antimicrobial therapy when indicated.
The management of patients with chronic otitis externa includes cleansing and debridement accompanied by topical acidifying and drying agents. This is followed by topical antibiotics and corticosteroid preparations. Surgery is mainly used to allow cleansing and aeration and/or removal of the scarred tissue. Patients with acute localised otitis externa (furunculosis) are treated with local heat and systemic antibiotics in the inflammatory stage, and drainage in the abscess state. Mycotic external otitis is managed with topical acidifying and antifungal agents, while viral (herpes) infection is treated with topical and systemic aciclovir (acyclovir). Patients with necrotising (malignant) external otitis, which is mainly caused by P. aeruginosa and S. aureus, are treated with systemic antibiotics and, rarely, by surgical debridement. Therapy for eczematous otitis externa is first directed at the secondary infection, and thereafter at the primary dermatological condition. Prevention of recurrent external otitis is aimed at minimising ear canal trauma and the avoidance of exposure to water. Preventative use of topical acidifying agents or 70% alcohol is also advocated.
Similar content being viewed by others
References
Marcy SM. Infections of the external ear. Pediatr Infect Dis 1985 Mar-Apr; 4(2): 192–201
Bojrab DI, Bruderly TE, Abdulrazzak Y. Otitis externa. Otolaryngol Clin North Am 1996 Oct; 29(5): 761–82
Sobie S, Brodsky L, Stanievich JF. Necrotizing external otitis in children: report of two cases and review of the literature. Laryngoscope 1987 May; 97(5): 598–601
Senturia BH. External otitis, acute diffuse: evaluation of therapy. Ann Otol Rhinol Laryngol 1973 Sep-Oct; 82: 1–23
Brook I, Frazier EH, Thompson DH. Aerobic and anaerobic microbiology of external otitis. Clin Infect Dis 1992 Dec; 15(6): 955–8
Sade J, Lang R, Goshen S, et al. Ciprofloxacin treatment of malignant external otitis. Am J Med 1989 Nov; 87Suppl. 5A: 138S–41S
Zikk D, Rapoport Y, Redianu C, et al. Oral ofloxacin therapy for invasive external otitis. Ann Otol Rhinol Laryngol 1991 Aug; 100(8): 632–7
Brook I, Coolbaugh JC, Williscroft RG. Effect of diving and diving hoods on the bacterial flora of the external ear canal and skin. J Clin Microbiol 1982 May; 15(5): 855–9
Brook I, Coolbaugh JC. Changes in the bacterial flora of the external ear canal from the wearing of the occlusive equipment. Laryngoscope 1984 Jul; 94(7): 963–5
Martin-Hirsch DP, Smelt GJC. Conchal flap meatoplasty. J Laryngol Otol 1993 Nov; 107(11): 1029–31
Paparella MM. Surgical treatment of intractable external otitis. Laryngoscope 1966; 76(6): 1136–47
Gordon G, Giddings NA. Invasive otitis externa due to Aspergillus species: case report and review. Clin Infect Dis 1994 Nov; 19(5): 866–70
Stern JC, Shah MK, Lucente FE. In vitro effectiveness of 13 agents in otomycosis and review of the literature. Laryngoscope 1988 Nov; 98(11): 1173–7
Selesnick SH, Patwardhan A. Acute facial paralysis: evaluation and early management. Am J Otolaryngol 1994 Nov-Dec; 15(6): 387–408
Murakami S, Hato N, Horiuchi J, et al. Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol 1997 Mar; 41(3): 353–7
Crabtree JA. Herpes zoster oticus and facial paralysis. Otolarygol Clin North Am 1974 Jun; 7(2): 369–73
Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med 1988 Sep; 85(3): 391–8
Kohut RI, Lindsay JR. Necrotizing (‘malignant’) external otitis histopathologic processes. Ann Otol Rhinol Laryngol 1979 Sept–Oct; 88 (5 Pt 1): 714–20
Schwarz GA, Blumenkrantz MJ, Sundmaker WLH. Neurologic complication of malignant external otitis. Neurology 1971 Nov; 21(11): 1077–84
Watson RC, Cancilla PA, Aschenbrener CA, et al. The neuropathology of malignant external otitis. Bull Los Angeles Neurol Soc 1977 Jul; 42(2): 51–6
Evans IT, Richards SH. Malignant (necrotizing) otitis externa. J Laryngol Otol 1973 Jan; 87(1): 13–20
Johnson MP, Ramphal R. Malignant external otitis: report on therapy with ceftazidime and review of therapy and prognosis. Rev Infect Dis 1990 Mar-Apr; 12(2): 173–80
Chandler JR. Pathogenesis and treatment of facial paralysis due to malignant external otitis. Ann Otol Rhinol Laryngol 1972 Oct; 81(5): 648–58
Davis JC, Gates GA, Lerner C, et al. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg 1992 Jan; 118(1): 89–93
Gilain L, Labroue M, Aidan D, et al. Value of hyperbaric oxygen therapy in the treatment of malignant otitis externa: apropos of a case. Ann Otolaryngol Chir Cervicofac 1993; 110(1): 50–4
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brook, I. Treatment of Otitis Externa in Children. Pediatr-Drugs 1, 283–289 (1999). https://doi.org/10.2165/00128072-199901040-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128072-199901040-00004